“Letter to the Editor Regarding the Article ‘Use of Autologous Dendritic Cell Vaccine CaTeVac in Melanoma Patients: Final Results of the DENDRON-01 Study’”, Вопр. онкол., vol. 72, no. 1, p. OF-2542, Mar. 2026, doi: 10.37469/0507-3758-2026-72-1-OF-2542.